help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Journal of Clinical Endocrinology & Metabolism Vol. 58, No. 1 157-160
doi:10.1210/jcem-58-1-157
Copyright © 1984 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOCCAFONDI, R. S.
Right arrow Articles by MELANDER, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOCCAFONDI, R. S.
Right arrow Articles by MELANDER, A.

Vasoactive Intestinal Peptide Stimulation of Human Thyroid Cell Function*

ROBERTO S. TOCCAFONDI, MARIA LUISA BRANDI and ARNE MELANDER

Department of Medicine, University of Florence Florence, Italy Department of Clinical Pharmacology (Malmö General Hospital), University of Lund Malmö, Sweden

Address all correspondence and requests for reprints to: Dr. Arne Melander, Head, Department of Clinical Pharmacology, Malmo General Hospital, S-214 01 Malmo, Sweden.

Neurons containing vasoactive intestinal peptide (VIP) have been found to reach thyroid follicular cells in man and other mammals. Human thyroid cells in culture were exposed to different concentrations of VIP and TSH, and thyroid cell activation was assessed by measurements of cAMP accumulation. VIP exerted a dose-dependent activation, and this thyroid-stimulating effect was more rapid and short-acting than that of TSH. At low concentrations of the two agents, their effects were additive, but they seemed to initiate their effects via different receptors, since polyphloretin phosphate inhibited the effect of TSH but not that of VIP. Moreover, antiadrenergic and anticholinergic agents did not influence thyroid activation by VIP. In addition to cAMP activation in cell cultures, VIP stimulated T4 release from human thyroid slices. It is possible that, in addition to sympathetic-adrenergic and parasympathetic- cholinergic nerves, VIPergic nerves may participate in the autonomic nervous control of thyroid function.

* This work was supported by Grant 80/01467/96 of the project "Control of Tumor Growth" of the National Research Council, Rome, Italy, and by Grant 3880 from the Swedish Medical Research Council.

Received February 7, 1983.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society